Abstract
Background
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver.
Aims
The aim of this study was to describe the prevalence, trends, and predictors of metastatic HCC on a national scale.
Methods
We used two nationwide datasets for our study: the University Health Consortium (UHC) and the Nationwide Inpatient Sample (NIS) databases. We included adults with a primary diagnosis of HCC from 2000 to 2011. We collected information regarding demographics, insurance, HCC risk factors, liver decompensation, and the sites and frequencies of metastases. Multivariable regression analysis was used to examine predictors of metastatic HCC. Trend analysis was performed to examine the change in metastatic HCC prevalence over time.
Results
We included 25,671 and 26,054 HCC patients from UHC and NIS, respectively. Prevalence of metastatic HCC was 18 % with lung being the most frequent site (31 %). Compared with Caucasian, African American ethnicity was an independent predictor of metastasis in both the NIS [OR 1.13 (1.02–1.25)] and UHC [OR 1.4 (1.3–1.6)] databases. Lack of long-term insurance was associated with significantly higher prevalence of metastasis in both the NIS [OR 1.6 (1.4–1.9)] and UHC [OR 1.9 (1.6–2.2)] databases. There has been an increased prevalence of metastatic HCC over the last decade with an annual percentage change of +1.25 and +1.60 % (p = 0.03 and p = 0.08) for the NIS and UHC databases, respectively.
Conclusions
Metastasis is not rare among HCC patients and is rising in prevalence over the last decade. Lungs were the most common metastatic site. Ethnicity and insurance status are independent predictors of metastasis.
Similar content being viewed by others
References
Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 2010;42:S206–S214.
El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res. 2007;37:S88–S94.
El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–1127.
El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264–1273; e1261.
Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–524.
Tang ZY. Hepatocellular carcinoma–cause, treatment and metastasis. World J Gastroenterol. 2001;7:445–454.
Shuto T, Hirohashi K, Kubo S, et al. Treatment of adrenal metastases after hepatic resection of a hepatocellular carcinoma. Dig Surg. 2001;18:294–297.
Fukutomi M, Yokota M, Chuman H, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2001;13:1083–1088.
Seinfeld J, Wagner AS, Kleinschmidt-DeMasters BK. Brain metastases from hepatocellular carcinoma in US patients. J Neurooncol. 2006;76:93–98.
Natsuizaka M, Omura T, Akaike T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol. 2005;20:1781–1787.
Duggal R, Garg M, Kalra N, Srinivasan R, Chawla Y. Spleen metastasis from hepatocellular carcinoma: report of a case with diagnosis by fine needle aspiration cytology. Acta Cytol. 2010;54:783–786.
Longo R, Mocini D, Santini M, et al. Unusual sites of metastatic malignancy: case 1. Cardiac metastasis in hepatocellular carcinoma. J Clin Oncol. 2004;22:5012–5014.
Kolarević D, Tomasević Z, Boricić I, et al. Metastasis of hepatocellular carcinoma presented as a tumor of the maxillary sinus and retrobulbar tumor. Vojnosanit Pregl. 2011;68:359–362.
Lin CP, Cheng JS, Lai KH, et al. Gastrointestinal metastasis in hepatocellular carcinoma: radiological and endoscopic studies of 11 cases. J Gastroenterol Hepatol. 2000;15:536–541.
Liang HH, Wu CH, Tam KW, Chai CY, Lin SE, Chen SC. Thyroid metastasis in a patient with hepatocellular carcinoma: case report and review of literature. World J Surg Oncol. 2007;5:144.
Kim HS, Shin JW, Kim GY, et al. Metastasis of hepatocellular carcinoma to the small bowel manifested by intussusception. World J Gastroenterol. 2006;12:1969–1971.
Kunizaki M, Hidaka S, Isomoto H, et al. Diagnosis of small-bowel metastasis of hepatocellular carcinoma by double-balloon enteroscopy. Int J Surg Case Rep. 2012;3:263–265.
Lee YT, Geer DA. Primary liver cancer: pattern of metastasis. J Surg Oncol. 1987;36:26–31.
Katyal S, Oliver JH, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology. 2000;216:698–703.
Yoo SJ, Cheon JH, Lee SW, et al. Extrahepatic metastasis of hepatocellular carcinoma to the nasal cavity manifested as massive epistaxis: a case report. Korean J Hepatol. 2004;10:228–232.
University Health Consortium. http://www.uhc.edu. Accessed 9/5/2014.
(HCUP) HCaUP. National Inpatient Sample. http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 9/4/2014.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619.
Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97:134–147.
Simons JP, Ng SC, Hill JS, Shah SA, Zhou Z, Tseng JF. In-hospital mortality from liver resection for hepatocellular carcinoma: a simple risk score. Cancer. 2010;116:1733–1738.
Institute NC. Joinpoint Regression Program. 2011; http://surveillance.cancer.gov/joinpoint/. Accessed 2/10/2012.
Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28:3670–3682.
Sloane D, Chen H, Howell C. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc. 2006;98:1934–1939.
Davila JA, El-Serag HB. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol. 2006;4:104–110; quiz 104–105.
Smith-Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996–2010. JAMA. 2012;307:2400–2409.
Acknowledgments
Ali Abbas contributed to study concept and design; acquisition of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content; and statistical analysis. Sabeen Medvedev contributed to acquisition of data, drafting of the manuscript; critical revision of the manuscript. Nathan Shores contributed to interpretation of data; critical revision of the manuscript. Lydia Bazzano contributed to study design critical revision of the manuscript and the analysis. Ahmed Dehal contributed to acquisition of data, drafting of the manuscript; critical revision of the manuscript. Jay Hutchings contributed to acquisition of data, critical revision of the manuscript, and study supervision. Luis Balart contributed to critical revision of the manuscript for important intellectual content, study supervision.
Conflict of interest
All authors have no potential conflicts (financial, professional, or personal) that are relevant to this manuscript. The study was conducted, and the manuscript was written and reviewed solely by the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abbas, A., Medvedev, S., Shores, N. et al. Epidemiology of Metastatic Hepatocellular Carcinoma, A Nationwide Perspective. Dig Dis Sci 59, 2813–2820 (2014). https://doi.org/10.1007/s10620-014-3229-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-014-3229-9